{{Rsnum
|rsid=2629751
|Gene=GLT8D2
|Chromosome=12
|position=104028030
|Orientation=plus
|GMAF=0.3421
|Gene_s=GLT8D2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.4 | 47.8 | 8.8
| HCB | 46.0 | 48.2 | 5.8
| JPT | 38.1 | 56.6 | 5.3
| YRI | 25.9 | 49.0 | 25.2
| ASW | 38.6 | 45.6 | 15.8
| CHB | 46.0 | 48.2 | 5.8
| CHD | 48.6 | 45.9 | 5.5
| GIH | 50.5 | 38.6 | 10.9
| LWK | 32.7 | 49.1 | 18.2
| MEX | 39.7 | 39.7 | 20.7
| MKK | 57.1 | 38.5 | 4.5
| TSI | 52.0 | 36.3 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22841784
  |Trait=Hepatitis C induced liver fibrosis
  |Title=Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection.
  |RiskAllele=G
  |Pval=1E-7
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}